BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9200684)

  • 1. Cardiac muscarinic receptors. Cooperativity as the basis for multiple states of affinity.
    Chidiac P; Green MA; Pawagi AB; Wells JW
    Biochemistry; 1997 Jun; 36(24):7361-79. PubMed ID: 9200684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac muscarinic receptors. Relationship between the G protein and multiple states of affinity.
    Green MA; Chidiac P; Wells JW
    Biochemistry; 1997 Jun; 36(24):7380-94. PubMed ID: 9200685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of paired M2 muscarinic receptors.
    Potter LT; Ballesteros LA; Bichajian LH; Ferrendelli CA; Fisher A; Hanchett HE; Zhang R
    Mol Pharmacol; 1991 Feb; 39(2):211-21. PubMed ID: 1899905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irreversible binding of acetylethylcholine mustard to cardiac cholinergic muscarinic receptors.
    Baker SP; Posner P
    Mol Pharmacol; 1986 Nov; 30(5):411-8. PubMed ID: 3773882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The binding of a 2-chloroethylamine derivative of oxotremorine (BM 123) to muscarinic receptors in the rat cerebral cortex.
    Ehlert FJ; Jenden DJ
    Mol Pharmacol; 1985 Aug; 28(2):107-19. PubMed ID: 3839562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of ligand choice on the apparent binding profile of gallamine to cardiac muscarinic receptors. Identification of three main types of gallamine-muscarinic receptor interactions.
    Lee NH; el-Fakahany EE
    J Pharmacol Exp Ther; 1988 Sep; 246(3):829-38. PubMed ID: 3418516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of mechanistic proposals for the binding of agonists to cardiac muscarinic receptors.
    Wong HM; Sole MJ; Wells JW
    Biochemistry; 1986 Nov; 25(22):6995-7008. PubMed ID: 3801407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of cardiac muscarinic receptors recognized selectively by nonquaternary but not by quaternary ligands.
    Brown JH; Goldstein D
    J Pharmacol Exp Ther; 1986 Aug; 238(2):580-6. PubMed ID: 3016242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recovery of oligomers and cooperativity when monomers of the M2 muscarinic cholinergic receptor are reconstituted into phospholipid vesicles.
    Ma AW; Redka DS; Pisterzi LF; Angers S; Wells JW
    Biochemistry; 2007 Jul; 46(26):7907-27. PubMed ID: 17552496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion of N-(2-chloroethyl)-4-piperidinyl diphenylacetate (4-DAMP mustard) to an aziridinium ion and its interaction with muscarinic receptors in various tissues.
    Thomas EA; Hsu HH; Griffin MT; Hunter AL; Luong T; Ehlert FJ
    Mol Pharmacol; 1992 Apr; 41(4):718-26. PubMed ID: 1569923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of binding of muscarinic receptor antagonists in rat brain homogenates.
    Lee JH; el-Fakahany EE
    J Pharmacol Exp Ther; 1985 Jun; 233(3):707-14. PubMed ID: 3839264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperativity manifest in the binding properties of purified cardiac muscarinic receptors.
    Wreggett KA; Wells JW
    J Biol Chem; 1995 Sep; 270(38):22488-99. PubMed ID: 7673239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115). Selective loss with subculturing of the low-affinity agonist site mediating cyclic GMP formation.
    McKinney M; Stenstrom S; Richelson E
    Mol Pharmacol; 1984 Sep; 26(2):156-63. PubMed ID: 6148690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesterol as a determinant of cooperativity in the M2 muscarinic cholinergic receptor.
    Colozo AT; Park PS; Sum CS; Pisterzi LF; Wells JW
    Biochem Pharmacol; 2007 Jul; 74(2):236-55. PubMed ID: 17521619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of pH on the binding of scopolamine and N-methylscopolamine to muscarinic receptors in the corpus striatum and heart of rats.
    Ehlert FJ; Delen FM
    Mol Pharmacol; 1990 Jul; 38(1):143-7. PubMed ID: 2370852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term desensitization of muscarinic cholinergic receptors in mouse neuroblastoma cells: selective loss of agonist low-affinity and pirenzepine high-affinity binding sites.
    Cioffi CL; el-Fakahany EE
    J Pharmacol Exp Ther; 1986 Sep; 238(3):916-23. PubMed ID: 3018226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding and hydrodynamic properties of muscarinic receptor subtypes solubilized in 3-(3-cholamidopropyl)dimethylammonio-2-hydroxy-1-propanesulfonate.
    Poyner DR; Birdsall NJ; Curtis C; Eveleigh P; Hulme EC; Pedder EK; Wheatley M
    Mol Pharmacol; 1989 Sep; 36(3):420-9. PubMed ID: 2506431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propylbenzilylcholine mustard has greater specificity for muscarinic m2 receptors than for m3 receptors present in cerebellar granule cell culture from rat.
    McLeskey SW; Wojcik WJ
    J Pharmacol Exp Ther; 1992 Nov; 263(2):703-7. PubMed ID: 1432698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between muscarinic receptor occupancy and adenylate cyclase inhibition in the rabbit myocardium.
    Ehlert FJ
    Mol Pharmacol; 1985 Nov; 28(5):410-21. PubMed ID: 4058422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of a radiolabeled agonist with cardiac muscarinic cholinergic receptors.
    Harden TK; Meeker RB; Martin MW
    J Pharmacol Exp Ther; 1983 Dec; 227(3):570-7. PubMed ID: 6317839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.